Rx-Spending Growth Slows But Remains One Of The Fastest Growing Sectors
February 15, 2017
Drug spending growth slowed from 9 percent in 2015 to 6 percent last year due to a drop in use of hepatitis C drugs, according to 2016 projections that the CMS actuary's office reported Wednesday (Feb. 15). The actuaries' projections of health-spending growth overall are slightly slower than they were last year, even though spending in Medicare and Medicaid is expected to speed up a bit, and the ACA's Independent Payment Advisory Board is still projected to be triggered this...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans look to their next steps following the collapse of their efforts to repeal and replace.